Abu Dhabi hospitals mark info networking milestone

A key milestone marking the technological progression of healthcare in Abu Dhabi emirate was put in place 10 September with the announcement of the completion of a fully integrated clinical information network. The new hospital information system currently links three key government hospitals and a number of Primary Healthcare Centres (PHC) in the emirate, according to Perot Systems, the company that was brought in to project-manage the initiative.

Key to this digital network is the Electronic Medical Record (EMR), which provides a centralised platform for the management of patient information. The system is also expected to significantly enhance administrative efficiency.

Speaking exclusively to Middle East Health, Dr Kevin Fickenscher, Executive Vice President, Perot Systems’ international healthcare group, explained that Perot Systems was called in by the Health Authority of Abu Dhabi in 2007 to oversee the project. A new government company Abu Dhabi Health Services Company (SEHA) has since been established to run the 468-bed Tawam Hospital, 550-bed Sheikh Khalifa Medical City and 235-bed Al Corniche Hospital, which have been linked up with the clinical information network.

SEHA owns and operates eight hospital systems, totalling 14 hospitals and more than 55 ambulatory and PHCs in the emirate and the network solution is expected to be completely rolled out across the organisation over the next few years.

“Abu Dhabi initiated the project about two years ago, but once they got into it they realised they needed support and that’s when they called us in. This was about a year ago,” said Dr Fickenscher.

“We managed to get them to delay its implementation so we could work with the hospitals involved.”

He explained that working with the hospitals is vital to the success of such networking initiatives.

“Perot Systems has very deep experience managing the implementation of hospital information systems,” he said. In the United States the company is the leader in this field.

“We use what we call the ADOPT framework,” Dr Fickenscher explained. “That is: Assess; Define; Optimise; Prepare; Transform; and Sustain.

“In a nutshell we go in and ‘assess’ what the organisation wants, what their needs are. We then ‘define’ these before ‘optimising’ specific information tools for them. In the case of SEHA we used Cerner’s Millennium Hospital Information System. We then prepare the organisation for the change. We implement the change – ‘transform’ – then ‘sustain’ the system by ensuring the organisation defines clear metrics about what it is trying to accomplish. Their top objectives would be cost and quality issues.”

In May this year Cerner announced the completion of the implementation of the Millennium solution at Tawam hospital in Al Ain, Abu Dhabi emirate. The company said then that the Cerner Millennium solution will eventually link all SEHA facilities in Abu Dhabi.

The clinical network solution automates processes in the radiology, pathology, pharmacy, surgery, emergency, and scheduling and registration departments. Clinicians also use the platform to document care and submit orders in the EMR.

Dr Fickenscher said Perot Systems, a Texas, US headquartered provider of information technology services, is experiencing rapid growth in the healthcare sector.

“In healthcare we’re experiencing 15-20% growth. If we continue at this pace of growth we have to place more focus on the international markets, which currently accounts for only 3% of business. [The US accounts for the bulk of it. In 2007 the company reported revenue of US$2.6 billion]. We want to increase this to 10% by 2012.”

He said the big markets outside the US are the UK and Europe, but the big growth markets are the Middle East, particularly the GCC, China and India.

Speaking to Middle East Health from China where he was due to make a presentation in Hunan province, Dr Fickenscher said Perot Systems was looking at expanding their business in the Middle East. “We’re in talks with the Royal Court of Jordan and have had proposals from Dubai and Bahrain.”

Saudi MoH issues Hajj vaccination requirements

Saudi Arabia’s Ministry of Health has called on all ministries of health of the Islamic countries as well as all countries sending pilgrims and Umrah performers to abide by the health requirements which should be carried out by those coming to perform Hajj and Umrah for this year 1429 H.

Pilgrims coming from all countries would be required to present vaccination certificates for meningitis.

Pilgrims coming from countries infected by Yellow Fever, particularly those in Africa and Bolivia, Ecuador and Colombia would have to show proof of vaccination against the disease.

Children under the age of 15 from Africa as well as pilgrims from Yemen, Nepal, India and Pakistan should show proof that they have been vaccinated for polio before their departure to Saudi Arabia.

Dubai Health Authority outlines new strategy

The Dubai Health Authority (DHA) has unveiled the government’s new strategic healthcare plan. Following a year of consultations with some 700 companies and 500 experts in 10 countries, as well as speaking to some 50 insurance companies, the DHA says it has devised a strategic plan for the provision of “good, affordable health services that meets people’s basic medical needs”. The plan will be implemented in a “phased transition that will take upwards of four years”.

Under the new scheme the DHA will be responsible for strategic planning, health policy, health regulation and health funding. The DHA will relinquish direct control over the provision of health services. The responsibility for this will be taken up by a new public corporation. Government hospitals and primary healthcare centres will be responsible for their own service planning and delivery, providing them with more flexibility thereby increasing their efficiency and effectiveness.

A regulatory body will be created to oversee all healthcare professionals and health services in the emirate. These will be inline with the UAE Ministry of Health and Health Authority of Abu Dhabi.

A new health funding system will be implemented. It will be mandatory for every resident in Dubai to have health insurance. Government will pay for nationals. In the case of expatriates, payment will be the responsibility of the employer. For the selfemployed it will be the responsibility of the individual. For dependents the sponsors of the dependents will be legally obliged to pay the so-called Health Benefits Contribution. All residents will be obliged to register annually for a health card which will give them access to a public or private healthcare facility.

A spokesperson for the DHA transition team said the health insurance reforms will be implemented gradually so as not to create a sudden extra burden for businesses in Dubai. There will be multiple health insurance providers. The team said they would announce details and dates of the phases of implementation later this year.

Qadhi Saeed Al Murooshid, the Director General of the DHA, said: “The DHA will be responsible for delivering a health strategy that protects and improves the quality of care for everyone in Dubai. We will promote international accreditation of all healthcare services and promote partnership between the public and the private sector.”

He said it is the DHA’s aspiration to become one of the top healthcare providers in the world and to have a reputation as a regional leader in healthcare provision. “To do this we must have transparency, accountability and unity,” he said.

● For more information, visit: www.dha.gov.ae  

Philips in strategic partnership with Dubai Health Authority

The Dubai Health Authority (DHA) and Royal Philips Electronics have sealed a strategic partnership (16 June 2008) through the signing of a Memorandum of Understanding, making Philips the preferred partner and supplier of healthcare, lighting and consumer products and services for future DHA healthcare projects in the emirate.

Philips said they would announce the first project resulting from the partnership within two months.

Qhadi Al Murooshid, the Director General of the DHA, said: “Like all prosperous countries our population will in the future be increasingly confronted with lifestylerelated chronic disease. While improving disease awareness and prevention we also realise we need to further strengthen our healthcare infrastructure to create one of the most advanced health systems in the world. Philips fits perfectly within this vision as Philips Healthcare combines human insight with clinical expertise to develop meaningful and relevant innovations that improve the access to healthcare and the quality of people’s lives wherever they might be – in the hospital or in the home.”

Louis Hakim, Vice President Royal Philips Electronics, CEO Philips Middle East, said: “We are proud to partner with the DHA and work with them to achieve positive change in healthcare for the future as this is one of the most pressing global issues of our time.”  

Half Afghan population vulnerable to malaria

Over half of Afghanistan's estimated 26.6 million population are vulnerable to malaria, according to Afghanistan’s Ministry of Public Health (MoPH).

MoPH says that 14 of the country's 34 provinces are identified as "high risk" areas where, plasmodium vivax, a malaria parasite, is prevalent, reports IRIN Afghanistan has the second highest number of malaria cases in the Eastern Mediterranean region, according to the World Health Organisation.

The MoPH and WHO estimate that every year up to 1.5 million cases of malaria occur throughout the country, but most go undiagnosed. While malaria treatment is included in MoPH's basic health services package, which reaches up to 85% of the population through 1,429 health facilities nationwide, there are not enough lab facilities to diagnose the disease.

Ranked the fifth least developed country in the world, Afghanistan does not have adequate resources, or the technical capacity to wipe out the parasite in the foreseeable future, health officials say.

The country is trying to control malaria within five years (2007-2012) with a US$28.3 million fund from the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria. To control the parasite the MoPH plans to distribute 1.2 million insecticide-treated bed nets to vulnerable communities, particularly in high-risk provinces, in 2008.  

New once-yearly treatment for osteoporosis launched  

Novartis has launched in the UAE a new osteoporosis drug – Aclasta – for the treatment of postmenopausal osteoporosis.

It is set to revolutionise osteoporosis treatment as the drug is administered only once a year. Aclasta (Zoledronic acid) is a concentrated form of bisphosphonate (BP) and its main mode of action is reversing the degenerative process of osteoporosis by inhibiting the release or loss of minerals from the bone.

It is the only bisphosphonate licensed for 3 types of fracture prevention; it reduces the risk of vertebral fracture by 70%, hip fracture by 41% and non-vertebral fractures by 25%. Aclasta was approved by the European Medicines Agency (EMEA) and US Food & Drug Administration (FDA) in 2007.

The treatment is available in more than 90 countries worldwide. In the Middle East the drug is available in Kuwait and the UAE.  

Yemen tetanus vaccination campaign  

The Yemeni government has intensified a campaign to spread awareness of the benefits of neonatal tetanus vaccinations to ensure the success of a second round of vaccinations that started on 7 June, reports IRIN.

The first round of the campaign fell below its intended target because of the unwillingness of some women to take the vaccination due to their belief that it would harm them in some way.

“We faced a number of obstacles during the campaign’s first round, which ran in mid- April,” Essa Mohammed, head of the Ministry of Health's National Programme for Extensive Vaccination (NPEV), told IRIN.

“It is not only women who reject taking the vaccines; men also reject them. A husband can stop his wife from taking the vaccine. The first round had a 74% success rate, which was below the aspired target [over 80%],” Mohammed said.

Mohammed added that there were false rumours among the population that the tetanus vaccine actually caused tetanus as it is manufactured in foreign countries that could not be trusted. “We tried to get support from a number of women’s organisations in spreading awareness. We also got support from preachers in mosques,” he said.

With 553 fixed teams and 1,290 mobile teams, Yemen’s neonatal tetanus vaccination campaign is targetting 912,196 women in the governorates of Ibb, al-Dhalei, Lahj and al-Hudeidah.

The second round is targetting 664,776 women and a third round will be undertaken in a few months' time. According to UNICEF, Yemen is among 47 countries in the world which has yet to eliminate neonatal and maternal tetanus.  

Saudi gives $1.8 million for Pakistan healthcare  

Two-and-a-half years after the devastating earthquake of October 2005 in Pakistan that killed at least 73,000 people, some survivors still lack access to basic healthcare.

Most of the limited services in the quake-hit areas of northern Pakistan and Pakistan-administered Kashmir were destroyed and it has not been possible to adequately replace them, reports IRIN.

Addressing this urgent need, the Saudi Public Assistance for Pakistan Earthquake Victims (SPAPEV), set up soon after the disaster, has contributed US$1.8 million to the UN Children's Fund (UNICEF) in Pakistan to construct five basic health units (BHUs) in quakehit areas.

Two of these are under construction – one is in Abbotabad in the North West Frontier Province and another in Muzaffarabad, capital of Pakistani-administered Kashmir. Work on the three other centres is to begin soon. The BHUs will provide primary care to about 60,000 people, including children and women.

“About 75%of health facilities were destroyed or significantly damaged in this remote and inaccessible region. Even before the earthquake, the health system was very weak,” Martin Mogwanja, the UNICEF country representative for Pakistan, told IRIN in Islamabad.  

New hospital inaugurated at Dubai Healthcare City  

The Dh150 million (US$40.8 million) Dr Sulaiman Al Habib Medical Centre at Dubai Healthcare City (DHCC) was inaugurated in May by Qhadi Al Murooshid, Director General, Dubai Health Authority.

The new multi-specialty medical centre will have more than 120 doctors and a capacity to treat nearly 800 patients a day. Dr Sulaiman Al Habib, Chairman, said: “We are privileged to be associated with a landmark destination such as Dubai Healthcare City, which marks our growth from a modest medical unit in Saudi Arabia into a major healthcare group.

“Our sophisticated medical centre at DHCC will offer premium services on par with global entities, reflecting the most stringent standards.

It will not only complement the UAE’s healthcare infrastructure, but will also grow into a core facility for the entire Middle East region.” Dr Suleiman Al Habib Medical will provide integrated healthcare services in cardiology, pathology, dental care, and dermatology.

It will also include a diabetic centre, and offer speciality treatment in nutrition, gastroenterology, ophthalmology, and general surgery.  

UAE launches Relief pain awareness initiative  

The UAE Ministry of Health, Ministry of Education, Health Authority of Abu Dhabi and the Emirates Medical Association have joined forces for the launch of a national awareness campaign on pain management called Relief.

Relief aims to tackle the issue of daily pain, pain management and how awareness can improve the wellbeing of individuals in UAE. The economic cost of pain is massive. Headaches alone are estimated to result in significant loss of productivity.

A recent study published by the Centre for Adaptive Disorders and Headache at the University of Pavia in Italy found that 4-5% of the global population suffers from chronic daily headache. Headache is identified as the most common form of untreated pain worldwide, which cost millions of dollars in lost productivity. The Relief campaign will create awareness in the UAE community on how pain is caused and why it is important that pain is managed effectively.

This initiative will be rolled out in shopping malls, schools and hospitals over the next several months. Dr Haifa Hamad Fares, Family Medicine Specialist for the UAE Ministry of Health, said the MoH was proud to support the relief campaign.

“Poor pain management often leads to more serious complications and long term consequences. With proper levels of education amongst the public about proper pain management we will be able to help reduce long-term productivity loss due to pain. Pain has a dramatic impact on productivity, but it can be managed, reduced or even eliminated.”

Professor Joseph Shokry Costandi, the Head of Department of Anesthesia and Intensive Care and the Director of tyhe Pain Clinic at Al Qassimi Hospital, explained that pain can take many forms.

There is acute pain as a result of tissue damage. There is chronic pain which has “no apparent biological value that has persisted beyond the normal tissue healing time, usually taken to be three months”. And there is psychological pain.

“It is important to remember that all pain is subjective.” He added that often, due to a lack of awareness and knowledge, people with pain suffer in silence. He noted that pain has many impacts: physical, emotional, economic and social.

There have been several international pain awareness campaigns over the past 10 years including: The Global Year Against Pain in the Elderly launched in 2006; Global Year Against Pain in Women launched 2007; and the Global Year Against Fibromyalgia will be launched on 20 October this year.

● For more information about pain and pain management, visit: The International Association for the Study of Pain. www.iasp-pain.org  

Rheumatoid Arthritis summit held in Cairo  

Rheumatoid Arthritis affects one person in a hundred in the Middle East and, according to the World Health Organisation (WHO), is responsible for considerable economic burden due to work disability. These facts were highlighted at the 5th MENA Rheumatology Summit, in Cairo in May.

The summit, sponsored by Wyeth pharmaceuticals, discussed early treatment approaches and included a series of workshops on the role of biological treatments in Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis.

Speaking at the summit, Dr Ayman Mofty, Arthritis and Rheumatism Specialist, American Hospital Dubai, said: “The success of treating an RA patient relies on early diagnosis and evaluation. Early effective treatment may not only postpone and slow disease progression, thereby improving quality of life, but also decrease costs by preserving productivity and reducing the need for surgery. Assessment tools and treatment guidelines are essential to ensure that RA patients continue to receive the best treatment.”

Dr Mofty, said: “The treatment of RA has changed considerably within the past decade, moving from a conservative approach designed to control clinical symptoms to a more aggressive approach designed to limit joint destruction. Biological medications such as Enbrel (etanercept) in combination with other treatments have been particularly successful in achieving this goal.”

Enbrel is the first biologic therapy and the first human soluble tumour necrosis factor (TNF) receptor to be approved by the US FDA and the European Medicines Evaluation Agency (EMEA) for the treatment of RA and is the first and only biologic therapy approved to treat juvenile chronic arthritis (JCA) and psoriatic arthritis.  

German neurology centre opens at DHCC  

The German Center for Neurology and Psychiatry (GNP) has opened in Dubai Healthcare City (DHCC). Dr Arne Brosig, one of Germany’s leading specialists, will head up the centre.

He explained that the multispecialty clinic will bring some of the best expertise in the world to Dubai, reducing the need for future outbound travel for health.

The centre, which is open six days a week, is equipped with the latest technology used to diagnose and treat neurological and psychiatric conditions, ranging from schizophrenia to strokes.

Brosig said: “The need for electroneurography, a service we will be offering using the best technology on the market, is particularly crucial for the UAE as diabetes is one of the most prevalent diseases in the emirates. If you develop diabetes, you are at very high risk of encountering neurological diseases throughout your life.”

She said: “Many prejudices and unnecessary fears are still prevalent in society when it comes to neurological deficits or mental illness. In the Middle East neurological and psychiatric medicine is still developing and will be very new to many people so it is even more important to educate the population about the associated disorders and warning signs.

GNP, which has been operational in Germany since 1981, will provide neurology, psychiatry, psychotherapy, as well as neuropaediatric and rehabilitation expertise.  

Saudi medical university development underway  

His Highness King Abdullah of Saudi Arabia in May laid the foundation stone of the King Saud University for Health Sciences in Riyadh.

Spread across an area of five million square metres close to the King Abdul Aziz Medical City in Riyadh, the new university campus will also accommodate the King Abdullah International Research Center, a children's hospital, a medical museum, a conference centre and an academic district for girls.

The university will comprise a college of medicine, a college of nursing and allied medical sciences, a college of public health and health informatics, in addition to departments relating to academic affairs, training and development.

The project is expected to take three years to complete.

The university was established in an effort to promote medical education and meet the manpower needs of the National Guard hospitals.

Dubai’s Welcare Hospital celebrates 10th anniversary  

Dubai’s Welcare Hospital, a member of Dubai-based Welcare World Group, and one of the pioneers of the private healthcare sector in the United Arab Emirates, celebrated its 10th anniversary in May.

According to a spokesperson for the hospital, it has seen more than 266,000 patients in the past 10 years, and the Obs- Gyn unit has delivered more than 8,000 babies.

Sunny Varkey, Founder and Chairman of the Welcare Group, said: “For the past decade, the Welcare Hospital has played an important part in supporting the unprecedented growth of the United Arab Emirates. The hospital has provided all residents in the region with world class health care in a friendly and caring manner.”

WHO Patient Safety Solutions in Arabic  

The World Health Organisation’s World Alliance for Patient Safety and the Collaborating Centre for patient Safety (Joint Commission and Joint Commission International) have translated the nine Patient Safety Solutions into Arabic. They can be downloaded at: www.jcipatientsafety.org

The Patient Safety Solutions, released in May 2007, address the issues of look-alike sound-alike medication names; correct patient identification; hand-over communications; correct procedure at the correct body site; control of concentrated electrolyte solutions, medication accuracy; catheter and tubing misconnections; needle reuse and injection device safety; and hand hygiene. The basic purpose of the solutions is to provide recommendations – as an aide-memoire – for guiding the redesign of care processes to prevent human error reaching the patient.  

GE sets up joint venture with Saudi company  

GE Healthcare has established a joint venture with El Seif Development Group in Saudi Arabia – to be known as GE El Seif Healthcare Arabia.

The new company will drive the sale of GE Healthcare’s products in Saudi Arabia, and has an ownership ratio of 51:49 for GE and El Seif Development, respectively.

GE says the new joint venture is aligned with their “Early Health” vision for the future of healthcare.  

Diabetes seminar highlights new findings for region  

Some 71% of type 2 diabetes patients in the Middle East do not have their blood glucose under control, leaving them at an increased risk of developing diabetes-related complications. These are the findings of a large multinational study, the results of which were discussed at a sanofi-aventis media seminar in Dubai recently.

The seminar entitled: ‘Developing actions for better outcomes in diabetes care’ provided a number of new insights into diabetes management drawn from an on-going study – “International Diabetes Management Practices Study (IDMPS)” and other recently published data.

A key recommendation was that there should be more aggressive management of blood glucose level in type II diabetics. Guidelines published in Diabetes Care in 2006 call for the initiation of insulin therapy for type II diabetes as the most effective treatment for the early management of the disease.

“This will prevent the early onset of diabetes-related complications,” Dr Sami T. Azar, Professor of Endocrinology, American University of Beirut - Medical Center, Lebanon, pointed out.

The IDMPS highlighted a number of interesting findings regarding diabetes in the Middle East. Around 71% of people in the Middle East failed to keep their blood glucose levels below the internationally recommended 7% HbA1c. he global average is 65%. Obesity is also a major issue: measurements of body mass index and waist circumference of people with diabetes in the Middle East were above the global average.

Prof Azar pointed out that there remains resistance to the use of insulin in type II diabetes due to physician and patient misconceptions.

“Patients in the Middle East delay taking insulin for up to 11 years after onset. The problem is that the patients decline to take it and the physician agrees,” said Prof Azar, adding “but patients are not as afraid of taking insulin as physicians may think.”

He said the study also showed that some 43% of patients in the Middle East had not been tested for diabetes related complications, particularly of the eyes and feet.

“HbA1c tests need to be regular,” he said. “However, more than 80% of diabetics in the Middle East had not been tested in the past year.”

“You have to undergo the test regularly – at least twice a year – to know the glucose level to determine if therapy is working.”

He also noted that in several cases physicians are to blame. The study showed that, when asked, physicians thought around 40% of their patients were at target (<7% HbA1c), however, more than 70% of their patients were not at target.

Speakers at the seminar called for closer collaboration of healthcare professionals, patients and their families, and policy decision makers to tackle the growing epidemic of diabetes in the region. They also called for the establishment of more counselling groups, saying that patients are happier than expected to participate.  

DHCC appoints CEO of University Hospital  

Dubai Healthcare City (DHCC) has appointed James Kingsbury as Chief Executive Officer of its recently launched 400-bed University Hospital (UH).

The hospital will serve as a regional centre for life sciences research, postgraduate medical education, and secondary and tertiary medical services.

Kingsbury was previously the Executive Director and Senior Vice-President of the University Hospital and Health Alliance of Greater Cincinnati, United States.

Dr Muhadditha Al Hashimi CEO, DHCC, said: “We are privileged to have onboard an accomplished industry leader such as James Kingsbury. We are certain his track record of significant accomplishments will benefit the organisation and help showcase the University Hospital as an internationally renowned institution for research, education, technology, and patient services.”

Kingsbury said: “Dubai Healthcare City and University Hospital are unrivaled examples of exciting opportunities for healthcare in the Middle East. While I am excited about the challenges ahead, I look forward to leveraging my professional expertise to lead such a prestigious institution.”

As CEO of University Hospital, James Kingsbury will play an integral part in driving the hospital’s growth while positioning it as a renowned academic facility. He will work with the DHCC leadership to direct clinical operational planning and construction, while overseeing a comprehensive recruitment process to choose world-class regional and global professionals for the institution. Additionally, he will direct the finance and marketing departments, and formulate a permanent governance structure for the University Hospital.

Construction of the 1.4 million square feet University Hospital campus commenced in June 2007. When completed, UH will offer specialty programmes in oncology, neurology, neurosurgery, musculoskeletal health, orthopedics, diabetes, and metabolic diseases.

Additionally, the hospital will offer core programmes in dermatology, gastroenterology, neonatology, ENT, OB/GYN, ophthalmology, urology, reconstructive surgery, general surgery, and general medicine.

UH is scheduled to begin patient operations in early 2011.  

Sport programme launched to combat diabetes

Abu Dhabi’s Imperial College London Diabetes Centre (ICLDC), has launched I PLAY SPORTS, the fifth pillar in the award-winning ‘DIABETES.KNOWLEDGE. ACTION.’ public health awareness campaign.

I PLAY SPORTS will kickoff with a corporate community football tournament geared to promote the importance of an active lifestyle. It will take place during the holy month of Ramadan (in Abu Dhabi, 9-14 September 2008).

According to ICLDC’s Dr Maha Taysir Barakat, Consultant Endocrinologist and Medical & Research Director the football tournament is open to teams representing the public and private sector.

“The Centre is using sports as a vehicle to promote the importance of an active lifestyle in the prevention of diabetes and other related complications.

“The upcoming I PLAY SPORTS tournament is an opportunity for the business community to have fun, while allowing the players and supporters to be ambassadors of the diabetes awareness message across the UAE.”

She confirmed that ICLDC remains committed to diabetes awareness and education in the UAE and said that this event is a significant milestone of the centre’s awareness campaign. It is the fifth outreach activity, joining the I WONDER screening programme, I EAT RIGHT school lunch box drive, I COOK HEALTHILY recipe collection, and the WALK UAE walkathon.

“The good news is that a healthy lifestyle is the smart and simple way to treat and even prevent diabetes.

I PLAY SPORTS is set to encourage the corporate community to take-up a fun sporting activity such as football, as part of their regular routine,” Dr Maha said.


Copyright © 2008 MiddleEastHealthMag.com. All Rights Reserved.